Pulmonary Involvement in Systemic Vasculitis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Rheumatology Reports

• Publication date

  2017-07-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11926-017-0682-4PMID 28752492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WS6_1 Anti-MPO antibodies cause granulomatosis in mice: an animal model of GPA

  2017cited by this paper
• Interstital lung disease in ANCA vasculitis.

  2017cited by this paper
• Transbronchial Lung Cryobiopsy and Video‐assisted Thoracoscopic Lung Biopsy in the Diagnosis of Diffuse Parenchymal Lung Disease. A Meta‐analysis of Diagnostic Test Accuracy

  2017cited by this paper
• Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

  2017cited by this paper
• Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Retrospective Analysis of 74 Cases

  2017cited by this paper
• Pulmonary Vasculitis: Spectrum of Imaging Appearances.

  2016cited by this paper
• Revised International Chapel Hill Consensus Conference nomenclature of vasculitides

  2016influential reference
• Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice

  2016cited by this paper
• Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: A Series of 49 Patients and Review of the Literature: Erratum

  2015cited by this paper
• Pulmonary vasculitis.

  2015cited by this paper
• Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis

  2015cited by this paper
• Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan.

  2015cited by this paper
• Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

  2015cited by this paper
• Overview of the Pathogenesis of ANCA-Associated Vasculitis

  2015cited by this paper
• Reduced survival in microscopic polyangiitis patients with pulmonary fibrosis in a respiratory referral centre

  2015cited by this paper
• Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital‐Based Japanese Patients

  2015cited by this paper
• Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study

  2015cited by this paper
• Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.

  2015cited by this paper
• Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

  2015cited by this paper
• Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

  2014cited by this paper
• Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

  2014cited by this paper
• Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis

  2014cited by this paper
• Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.

  2014cited by this paper
• Diffuse pulmonary hemorrhage: clues to the diagnosis.

  2014cited by this paper
• Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist

  2013cited by this paper
• ANCA-associated Vasculitis Patients Have Defective Treg Function Exacerbated by Presence of a Suppression-Resistant Effector Population

  2013cited by this paper
• Efficacy of remission-induction regimens for ANCA-associated vasculitis.

  2013cited by this paper
• Antiplasmodial potential of extracts from two species of genus Blumea

  2013cited by this paper
• Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.

  2013cited by this paper
• Substantiation of the ethnopharmacological use of Conyza sumatrensis (Retz.) E.H.Walker in the treatment of malaria through in-vivo evaluation in Plasmodium berghei infected mice.

  2013cited by this paper
• Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

  2013cited by this paper
• Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab.

  2013cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population.

  2013cited by this paper
• Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones

  2012cited by this paper
• The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis

  2012cited by this paper
• Imaging findings in pulmonary vasculitis.

  2012cited by this paper
• Genetically distinct subsets within ANCA-associated vasculitis.

  2012cited by this paper
• Bioenhancing and antimycobacterial agents from Ammannia multiflora.

  2012cited by this paper
• Decreased Numbers of Blood Dendritic Cells and Defective Function of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

  2011cited by this paper
• Antiplasmodial activity of artecyclopentyl mether a new artemisinin derivative and its effect on pathogenesis in Plasmodium yoelii nigeriensis infected mice

  2011cited by this paper
• Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.

  2011cited by this paper
• Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity.

  2011cited by this paper
• ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process

  2011cited by this paper
• Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

  2011cited by this paper
• Potential antimalarials from Nigerian plants: a review.

  2011cited by this paper
• Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

  2010cited by this paper
• Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression

  2010cited by this paper
• Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis.

  2010cited by this paper
• Pulmonary haemorrhage in ANCA-associated vasculitis.

  2010cited by this paper
• In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense

  2010cited by this paper
• Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

  2008cited by this paper
• Germinal centre-like structures in Wegener's granuloma: the morphological basis for autoimmunity?

  2008cited by this paper
• Are West African plants a source of future antimalarial drugs?

  2007cited by this paper
• Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis.

  2006cited by this paper
• Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'.

  2006cited by this paper
• Drug discovery from medicinal plants.

  2005cited by this paper
• The evolving role of natural products in drug discovery

  2005cited by this paper
• The global distribution of clinical episodes of Plasmodium falciparum malaria

  2005cited by this paper
• Bacterial denitrification, nitric oxide and airway pH in CF

  2005cited by this paper
• Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

  2005cited by this paper
• Exhaled NO in diffuse alveolar haemorrhage

  2005cited by this paper
• Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody‐associated vasculitides

  2004cited by this paper
• Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

  2002cited by this paper
• Peripheral Blood and Granuloma CD4+CD28− T Cells Are a Major Source of Interferon-γ and Tumor Necrosis Factor-α in Wegener’s Granulomatosis

  2002cited by this paper
• Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

  2002cited by this paper
• Antiprotozoal activities of Colombian plants.

  2001cited by this paper
• In vitro screening of Indian medicinal plants for antiplasmodial activity.

  2001cited by this paper
• High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1.

  2001cited by this paper
• In vitro antiplasmodial activity of extracts of Tristaniopsis species and identification of the active constituents: ellagic acid and 3,4,5-trimethoxyphenyl-(6'-O-galloyl)-O-beta-D-glucopyranoside.

  2001cited by this paper
• In vitro and In vivo evaluation of betulinic acid as an antimalarial

  1999cited by this paper
• Pulmonary vasculitis.

  1998cited by this paper
• Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.

  1994cited by this paper
• Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells.

  1992cited by this paper
• New macrofilaricidal leads from plants?

  1990cited by this paper
• Synchronization of Plasmodium falciparum erythrocytic stages in culture.

  1979cited by this paper
• Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.

  1978cited by this paper

• Antineutrophil cytoplasmic antibody-associated vasculitides: Clinical manifestations and pulmonary involvement

  2024influential citation
• Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis

  2022cites this paper
• Risikostratifizierung bei ANCA-assoziierten Vaskulitiden

  2021cites this paper
• Clinical characteristics and outcomes in microscopic polyangiitis patients with renal involvement: a study of 124 Chinese patients

  2019cites this paper
• Unclassified Vasculitis with Episcleritis, Thrombophlebitis, Deep Vein Thrombosis, Pulmonary Vasculitis, and Intracranial Vasculitis: An Autopsy Case Report

  2019cites this paper
• PET/CT Findings of Granulomatosis With Polyangiitis Presenting as a Solitary Pulmonary Nodule and Mimicking Lung Cancer.

  2019cites this paper
• Microscopic Polyangiitis

  2019cites this paper
• Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review

  2018influential citation
• Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation

  2018cites this paper
• Pathogenesis of ANCA-Associated Pulmonary Vasculitis

  2018cites this paper
• Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital‐Based Japanese Patients

  2015cites this paper